pharma · Adenocarcinoma of Lung · Primary Sjögren's Syndrome
Peking University Biologics
Peking University People's Hospital
Peking University Biologics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
2018 Founded
8 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Founded
- 2018
- Employees
- 8
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Peking University Biologics projects
2 ClinicalTrials.gov programs sponsored by Peking University Biologics.
Peking University Biologics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Peking University Biologics have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.